Anne Gulbech Ording

2.4k total citations
90 papers, 1.6k citations indexed

About

Anne Gulbech Ording is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, Anne Gulbech Ording has authored 90 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 26 papers in Cardiology and Cardiovascular Medicine and 26 papers in Internal Medicine. Recurrent topics in Anne Gulbech Ording's work include Venous Thromboembolism Diagnosis and Management (26 papers), Atrial Fibrillation Management and Outcomes (14 papers) and Cancer Risks and Factors (11 papers). Anne Gulbech Ording is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (26 papers), Atrial Fibrillation Management and Outcomes (14 papers) and Cancer Risks and Factors (11 papers). Anne Gulbech Ording collaborates with scholars based in Denmark, United States and Sweden. Anne Gulbech Ording's co-authors include Henrik Toft Sørensen, Erzsébet Horváth–Puhó, Victor W. Henderson, Lars Pedersen, Kasper Adelborg, Priscila Corraini, Timothy L. Lash, Szimonetta Komjáthiné Szépligeti, Jens Sundbøll and Mette Nørgaard and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Anne Gulbech Ording

87 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Gulbech Ording Denmark	21	415	350	325	293	251	90	1.6k
Bea C. Tanis Netherlands	23	351 0.8×	326 0.9×	146 0.4×	168 0.6×	257 1.0×	43	1.9k
Thomas Wilke Germany	23	681 1.6×	88 0.3×	270 0.8×	315 1.1×	146 0.6×	166	1.8k
Siân Sweetland United Kingdom	13	247 0.6×	362 1.0×	256 0.8×	359 1.2×	128 0.5×	19	1.2k
Géric Maura France	14	444 1.1×	111 0.3×	210 0.6×	185 0.6×	100 0.4×	28	1.2k
Michele Sacco Italy	26	638 1.5×	146 0.4×	318 1.0×	131 0.4×	159 0.6×	80	2.8k
Mette Gislum Denmark	28	180 0.4×	632 1.8×	351 1.1×	114 0.4×	267 1.1×	40	2.1k
Sigrun Alba Johannesdottir Denmark	13	277 0.7×	88 0.3×	146 0.4×	275 0.9×	161 0.6×	15	1.1k
F.R. Rosendaal Netherlands	26	512 1.2×	85 0.2×	182 0.6×	633 2.2×	216 0.9×	56	2.3k
M. C. Chamberlain United States	12	235 0.6×	215 0.6×	365 1.1×	572 2.0×	769 3.1×	20	2.2k
Marten R. Nijziel Netherlands	24	165 0.4×	593 1.7×	103 0.3×	153 0.5×	176 0.7×	53	1.4k

Countries citing papers authored by Anne Gulbech Ording

Since Specialization

Citations

This map shows the geographic impact of Anne Gulbech Ording's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Gulbech Ording with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Gulbech Ording more than expected).

Fields of papers citing papers by Anne Gulbech Ording

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Gulbech Ording. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Gulbech Ording. The network helps show where Anne Gulbech Ording may publish in the future.

Co-authorship network of co-authors of Anne Gulbech Ording

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Gulbech Ording. A scholar is included among the top collaborators of Anne Gulbech Ording based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Gulbech Ording. Anne Gulbech Ording is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Akbari, Ashley, Adrian Edwards, Kate Lifford, et al.. (2025). Anti‐thrombotic therapy in patients with cancer at the end of life: A cohort study using population‐linked routinely collected data. British Journal of Haematology. 207(5). 2080–2090.

Søgaard, Mette, Martin Bach Jensen, Eric C. T. Geijteman, et al.. (2024). Use of antithrombotic therapy and the risk of cardiovascular outcomes and bleeding in cancer patients at the end of life: a Danish nationwide cohort study. Journal of Thrombosis and Haemostasis. 23(1). 190–200. 3 indexed citations

Ording, Anne Gulbech, Thomas Decker Christensen, Flemming Skjøth, et al.. (2024). Risk of Venous Thromboembolism in Patients With Stage III and IV Non–Small-Cell Lung Cancer: Nationwide Descriptive Cohort Study. Clinical Lung Cancer. 25(5). 407–416.e1. 4 indexed citations

Edwards, Adrian, Kathy Seddon, Anne Gulbech Ording, et al.. (2024). Involving patients and the public in cancer associated thrombosis research: A strategy for success. ORCA Online Research @Cardiff. 18. 100196–100196. 1 indexed citations

Ording, Anne Gulbech, Flemming Skjøth, Laurids Østergaard Poulsen, et al.. (2024). Time Toxicity of Systemic Anticancer Therapy for Metastatic Lung Cancer in Routine Clinical Practice: A Nationwide Cohort Study. JCO Oncology Practice. 21(9). 1316–1324. 7 indexed citations

Søgaard, Mette, et al.. (2024). Net Clinical Benefit of Oral Anticoagulation Among Frail Patients With Atrial Fibrillation: Nationwide Cohort Study. Stroke. 55(2). 413–422. 5 indexed citations

Søgaard, Mette, Anne Gulbech Ording, Flemming Skjøth, Torben Bjerregaard Larsen, & Peter Brønnum Nielsen. (2023). Effectiveness and safety of direct oral anticoagulation vs. warfarin in frail patients with atrial fibrillation. European Heart Journal - Cardiovascular Pharmacotherapy. 10(2). 137–146. 7 indexed citations

Overvad, Thure Filskov, Flemming Skjøth, Gregory Piazza, et al.. (2022). The Khorana score and venous and arterial thrombosis in patients with cancer treated with immune checkpoint inhibitors: A Danish cohort study. Journal of Thrombosis and Haemostasis. 20(12). 2921–2929. 19 indexed citations

Klungsøyr, Kari, Anders Engeland, Anders Ekbom, et al.. (2021). Cancer Risk in Individuals With Major Birth Defects: Large Nordic Population Based Case-Control Study Among Children, Adolescents, and Adults. Obstetrical & Gynecological Survey. 76(4). 191–193. 3 indexed citations

10.

Ording, Anne Gulbech, Flemming Skjøth, Mette Søgaard, et al.. (2021). Increasing Incidence and Declining Mortality After Cancer-Associated Venous Thromboembolism: A Nationwide Cohort Study. The American Journal of Medicine. 134(7). 868–876.e5. 20 indexed citations

11.

Trabert, Britton, Rebecca Troisi, Tom Grotmol, et al.. (2020). Associations of pregnancy-related factors and birth characteristics with risk of endometrial cancer : A Nordic population-based case-control study. Bergen Open Research Archive (BORA) (University of Bergen). 1 indexed citations

12.

Overvad, Thure Filskov, Torben Bjerregaard Larsen, Mette Søgaard, et al.. (2020). Cancer-associated venous thromboembolism and the non-vitamin K antagonist oral anticoagulants: a review of clinical outcomes and patient perspectives. Expert Review of Cardiovascular Therapy. 18(11). 791–800. 7 indexed citations

13.

Sköld, Camilla, Tone Bjørge, Anders Ekbom, et al.. (2020). Pregnancy-related risk factors for sex cord-stromal tumours and germ cell tumours in parous women: a registry-based study. British Journal of Cancer. 123(1). 161–166. 3 indexed citations

14.

Boysen, Anders Kindberg, Karen‐Lise Garm Spindler, Morten Høyer, et al.. (2018). Metastasis directed therapy for liver and lung metastases from colorectal cancer—A population‐based study. International Journal of Cancer. 143(12). 3218–3226. 18 indexed citations

15.

Schmidt, Sigrún Alba Jóhannesdóttir, Anne Gulbech Ording, Erzsébet Horváth–Puhó, Henrik Toft Sørensen, & Victor W. Henderson. (2017). Non-melanoma skin cancer and risk of Alzheimer’s disease and all-cause dementia. PLoS ONE. 12(2). e0171527–e0171527. 28 indexed citations

16.

Corraini, Priscila, Szimonetta Komjáthiné Szépligeti, Victor W. Henderson, et al.. (2017). Comorbidity and the increased mortality after hospitalization for stroke: a population‐based cohort study. Journal of Thrombosis and Haemostasis. 16(2). 242–252. 36 indexed citations

17.

Sundbøll, Jens, Kasper Adelborg, Anne Gulbech Ording, et al.. (2017). Risk of arterial and venous thromboembolism in patients with atrial fibrillation or flutter: A nationwide population-based cohort study. International Journal of Cardiology. 241. 182–187. 19 indexed citations

18.

Adelborg, Kasper, Erzsébet Horváth–Puhó, Anne Gulbech Ording, et al.. (2016). Heart Failure and Risk of Dementia: A Danish Nationwide Population-Based Cohort Study. European Journal of Heart Failure. 19(2). 253–260. 89 indexed citations

19.

Ording, Anne Gulbech, Erzsébet Horváth–Puhó, Timothy L. Lash, et al.. (2015). Does comorbidity interact with prostate cancer to increase mortality? A Danish cohort study of 45 326 prostate cancer patients diagnosed during 1995–2011. Acta Oncologica. 55(5). 611–618. 11 indexed citations

20.

Ording, Anne Gulbech, Erzsébet Horváth–Puhó, Jens Peter Garne, et al.. (2014). Impact of comorbidity on risk of venous thromboembolism in patients with breast cancer: a Danish population-based cohort study. BMJ Open. 4(6). e005082–e005082. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact